LAUREL HUBBARD: Open Payments
NPI 1437678679 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 25 payments from 8 companies in 2025. Trend: 2023 $425 · 2024 $665 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $149 |
| Abbott Laboratories | 4 | $83 |
| Kestra Medical Technology Services, Inc. | 4 | $74 |
| Novo Nordisk Inc | 2 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $36 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $15 |
Products named: REPATHA, CARDIOMEMS, Assure WCD, Wegovy, LifeVest, SAPIEN 3 Ultra RESILIA, LEQVIO, Flexitouch Plus.
Industry payments across IN — which companies pay providers there.
